[The treatment of ankylosing spondylitis with auranofin (Ridaura)]

Author(s): Grasedyck K, Schattenkirchner M, Bandilla K

Affiliation(s): Medizinische Klinik, Universitatskrankenhaus Hamburg-Eppendorf.

Publication date & source: 1990-03, Z Rheumatol., 49(2):98-9.

Publication type: Clinical Trial; English Abstract; Randomized Controlled Trial

Auranofin has no influence on axial skeleton manifestation of ankylosing spondylitis, neither on clinical complaints, nor on function and inflammatory parameters. Peripheral arthritis is possibly influenced positively, but this cannot be stated definitely because of the low number of cases in this study. This question must be analyzed in larger collectives, as alternatives to conventional therapy are needed for the treatment of peripheral joint involvement of ankylosing spondylitis.